| | | 62492 | | 04.10.2012 | | Boehringer Ingelheim (Schweiz) GmbH | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Jentadueto 2.5 mg/500 mg | Filmtabletten | Filmtabletten (Linagliptinum 2.5 mg, Metformin Hydrochlorid 500 mg) | A10BD11 | PI | | 02 | Jentadueto 2.5 mg/850 mg | Filmtabletten | Filmtabletten (Linagliptinum 2.5 mg, Metformin Hydrochlorid 850 mg) | A10BD11 | PI | | 03 | Jentadueto 2.5 mg/1000 mg | Filmtabletten | Filmtabletten (Linagliptinum 2.5 mg, Metformin Hydrochlorid 1000 mg) | A10BD11 | PI |
|
|
